Lv11
81 积分 2024-09-03 加入
Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity
8天前
已完结
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
28天前
已完结
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
28天前
已完结
Real‐World Evidence on Weight Loss and Safety With Semaglutide in Obesity Telehealth: A Large Retrospective Cohort Study
1个月前
已完结
Weight loss and body composition after compounded semaglutide treatment in a real world setting
1个月前
已完结
Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition: Systematic review and network meta-analysis
1个月前
已完结
Relative effects of genetically proxied glucagon‐like peptide‐1 receptor agonism on muscle and fat mass: A Mendelian randomization study
1个月前
已完结
Leucine supplementation modulates body composition and early weight rebound during GLP-1 receptor agonist therapy in diet-induced obese mice
1个月前
已完结
Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity
2个月前
已完结
Is Weight Loss–Induced Muscle Mass Loss Clinically Relevant?
2个月前
已完结
皖公网安备34019202002308
